Gram Research analysis of the TARGET-D trial shows that giving heart attack survivors vitamin D supplements adjusted to reach healthy blood levels did not significantly reduce major heart problems over 4+ years: 15.7% of the vitamin D group experienced heart attacks, strokes, death, or heart failure hospitalization compared to 18.4% in usual care. However, vitamin D did appear to reduce repeat heart attacks specifically by about half (3.8% vs 7.9%), though this was a secondary finding requiring further confirmation.
A major study of 630 heart attack survivors tested whether taking vitamin D supplements could prevent future heart problems. Researchers gave some patients vitamin D pills adjusted to reach healthy levels, while others received standard care. After following patients for over 4 years, the vitamin D group didn’t have fewer heart attacks, strokes, or deaths than the control group. While vitamin D deficiency is common in heart patients, this research shows that simply boosting vitamin D levels doesn’t protect the heart the way scientists hoped it might.
Key Statistics
A 2026 randomized controlled trial of 630 heart attack survivors found that targeted vitamin D supplementation did not significantly reduce major adverse cardiovascular events (15.7% vs 18.4%, P=0.40) over an average follow-up of 4.2 years, despite successfully raising vitamin D levels from an average of 25 ng/mL to target ranges.
In the TARGET-D trial, vitamin D supplementation appeared to reduce repeat heart attacks by approximately 48% (3.8% vs 7.9%, P=0.03), though this was a secondary outcome and requires confirmation in future studies.
According to research reviewed by Gram, 87% of heart attack patients in the TARGET-D trial had vitamin D deficiency at baseline (levels ≤40 ng/mL), yet correcting this deficiency through targeted supplementation did not prevent major heart problems.
The TARGET-D trial found that vitamin D supplementation did not reduce death rates in heart attack survivors (8.9% vs 9.2%, P=0.95) or prevent heart failure hospitalizations (4.2% vs 3.5%, P=0.65) over 4+ years of follow-up.
The Quick Take
- What they studied: Does giving heart attack survivors vitamin D supplements (with doses adjusted to reach healthy blood levels) prevent future heart attacks, strokes, heart failure, or death?
- Who participated: 630 people who had recently suffered a heart attack, with an average age of 63 years (78% were men). Most had very low vitamin D levels at the start of the study.
- Key finding: After 4+ years, 15.7% of the vitamin D group experienced major heart problems compared to 18.4% in the regular care group—a difference that wasn’t statistically significant. However, vitamin D did appear to reduce repeat heart attacks specifically (3.8% vs 7.9%).
- What it means for you: If you’ve had a heart attack, taking vitamin D supplements probably won’t prevent future heart problems, though it may have a small benefit for preventing another heart attack. Talk to your doctor about your individual risk factors rather than relying on vitamin D alone.
The Research Details
TARGET-D was a pragmatic randomized controlled trial, meaning it tested a real-world approach to vitamin D treatment rather than a rigid laboratory setting. Researchers enrolled 630 heart attack patients between 2017 and 2023 and randomly assigned them to two groups: one received targeted vitamin D supplementation with doses adjusted based on blood test results to maintain healthy levels (40-80 ng/mL), while the other group received usual medical care without special vitamin D management.
The vitamin D group started with doses of 5,000 IU (international units) and had their doses adjusted over time based on blood tests to keep vitamin D levels in the target range. Researchers followed both groups for an average of 4.2 years, tracking whether participants experienced major heart problems including death, heart attack, hospitalization for heart failure, or stroke.
This study design is particularly valuable because it mimics how doctors would actually treat patients in real clinics, rather than using a one-size-fits-all approach. The researchers stopped the study in March 2025 once they had enough data to answer their main question.
Previous studies showed that people with low vitamin D often have worse heart outcomes, leading scientists to wonder if boosting vitamin D could prevent heart disease. However, earlier vitamin D trials used fixed doses that didn’t account for individual differences in how people absorb and use vitamin D. This study was designed to test whether a smarter, personalized approach—adjusting doses based on blood tests—might work better. Understanding whether vitamin D truly helps prevent heart problems is important because millions of people take vitamin D supplements, and doctors need to know if it’s worth recommending specifically for heart protection.
This study has several strengths: it was a randomized controlled trial (the gold standard for testing treatments), included a substantial number of participants (630), had a long follow-up period (4+ years), and was published in a top-tier medical journal (European Heart Journal). The researchers successfully maintained high participation rates and tracked outcomes carefully. However, the study enrolled fewer participants than originally planned, which means some smaller effects might not have been detected. Additionally, most participants were men, so results may not apply equally to women.
What the Results Show
The main finding was that targeted vitamin D supplementation did not significantly reduce major adverse cardiovascular events. In the vitamin D group, 15.7% of participants experienced a major heart problem (death, heart attack, heart failure hospitalization, or stroke) compared to 18.4% in the usual care group. While this shows a trend favoring vitamin D, the difference was not statistically significant, meaning it could have occurred by chance.
When researchers looked at individual outcomes, they found an interesting pattern. For repeat heart attacks specifically, vitamin D appeared protective: only 3.8% of the vitamin D group had another heart attack compared to 7.9% in the usual care group—a difference that was statistically significant. This suggests vitamin D might help prevent repeat heart attacks even if it doesn’t prevent all heart problems.
For other outcomes, vitamin D made little difference. Death rates were nearly identical (8.9% vs 9.2%), heart failure hospitalizations were slightly higher in the vitamin D group (4.2% vs 3.5%), and strokes were slightly higher in the vitamin D group (1.6% vs 0.9%), though these differences weren’t statistically significant.
The study confirmed that vitamin D deficiency is extremely common in heart attack patients: 87% had vitamin D levels below 40 ng/mL at the start, and the average level was only 25 ng/mL. Despite successfully raising vitamin D levels in the treatment group, this improvement didn’t translate into broad heart protection.
Beyond the main outcomes, researchers noted that the vitamin D group did show a potential benefit for preventing repeat heart attacks (a 48% reduction in risk), which was the only individual outcome that reached statistical significance. This finding is intriguing because it suggests vitamin D might work differently for preventing a first heart problem versus preventing recurrent ones. However, this was a secondary finding, meaning it wasn’t the main question the study was designed to answer, so it requires confirmation in future research.
This study adds important evidence to a growing body of research suggesting that simply correcting vitamin D deficiency doesn’t prevent heart disease the way many scientists hoped. Previous observational studies (which tracked people over time without assigning them to treatment groups) found that people with low vitamin D had more heart problems, leading to the hypothesis that vitamin D supplementation would help. However, multiple randomized trials, including this one, have failed to show that vitamin D supplements reduce major heart events. The TARGET-D trial is particularly valuable because it used a smarter dosing strategy than previous trials, yet still didn’t find broad cardiovascular benefits. The possible benefit for repeat heart attacks is new and interesting but needs further investigation.
Several limitations should be considered when interpreting these results. First, the study enrolled fewer participants than originally planned, which reduces the statistical power to detect smaller effects. Second, the study population was 78% male and had an average age of 63, so results may not apply equally to women or older adults. Third, while researchers successfully raised vitamin D levels in the treatment group, they couldn’t ensure perfect adherence to the vitamin D regimen—some participants may not have taken their supplements consistently. Fourth, the study focused on heart attack survivors, so results may not apply to people with other types of heart disease or those without a history of heart problems. Finally, the study lasted an average of 4.2 years, which may not be long enough to see benefits that develop over decades.
The Bottom Line
Based on this research, taking vitamin D supplements specifically to prevent heart problems after a heart attack is not recommended as a primary strategy (low confidence for this specific use). However, if you have vitamin D deficiency, correcting it remains important for bone health and overall wellness—discuss appropriate vitamin D levels with your doctor. For heart attack prevention and recovery, focus on proven strategies like taking prescribed heart medications, exercising regularly, eating a heart-healthy diet, managing stress, and not smoking. Vitamin D may play a supporting role, but it shouldn’t replace these established treatments.
This research is most relevant to people who have had a heart attack and are considering vitamin D supplements for heart protection. It’s also important for cardiologists and primary care doctors deciding whether to recommend vitamin D supplementation to their heart patients. People without heart disease should note that this study doesn’t address whether vitamin D helps prevent a first heart attack. Individuals with vitamin D deficiency should still work with their doctor to achieve healthy levels for bone and overall health, even if heart protection isn’t guaranteed.
If vitamin D were going to prevent heart problems, researchers would expect to see benefits within the 4+ year follow-up period used in this study. Since no significant benefit appeared, waiting longer is unlikely to change the conclusion. However, the possible benefit for repeat heart attacks (which showed up in secondary analysis) might require longer follow-up or larger studies to confirm.
Frequently Asked Questions
Does vitamin D prevent heart attacks if you’ve already had one?
The TARGET-D trial found that vitamin D supplementation did not significantly prevent major heart problems in heart attack survivors over 4+ years. However, it may reduce the risk of repeat heart attacks specifically (3.8% vs 7.9%), though this finding needs confirmation in future research.
Should I take vitamin D supplements after a heart attack?
Discuss vitamin D supplementation with your cardiologist based on your individual vitamin D levels and overall health. While this study doesn’t support vitamin D specifically for heart protection, correcting vitamin D deficiency remains important for bone health. Focus on proven heart-protective strategies like medications, exercise, and diet.
How common is vitamin D deficiency in heart disease patients?
The TARGET-D trial found that 87% of heart attack patients had vitamin D deficiency (levels ≤40 ng/mL), with an average level of only 25 ng/mL. This shows vitamin D deficiency is extremely common in this population, though correcting it doesn’t guarantee heart protection.
What’s the best way to prevent another heart attack?
Proven strategies include taking prescribed heart medications (like statins and blood thinners), exercising regularly, eating a heart-healthy diet low in saturated fat, managing stress, quitting smoking, and maintaining healthy blood pressure and cholesterol. Vitamin D may play a supporting role but shouldn’t replace these established treatments.
Can vitamin D supplements harm your heart?
In the TARGET-D trial, vitamin D supplementation did not increase heart problems and showed no safety concerns. However, very high vitamin D levels can cause other health issues, so work with your doctor to maintain appropriate levels rather than self-supplementing with high doses.
Want to Apply This Research?
- Track vitamin D supplementation (dose and frequency) alongside heart health markers like blood pressure, heart rate, and any cardiac symptoms. Log this weekly to identify patterns and ensure consistency with your doctor’s recommendations.
- If your doctor recommends vitamin D supplementation, set daily reminders to take your vitamin D supplement at the same time each day (such as with breakfast). Use the app to log when you take it and schedule quarterly blood tests to monitor your vitamin D levels, ensuring your dose is appropriate.
- Create a long-term tracking dashboard that monitors vitamin D levels (via blood test results entered quarterly), adherence to supplementation, and key heart health metrics. Compare these trends over 6-12 months to assess whether your vitamin D levels are stable and whether your overall heart health is improving through comprehensive cardiac management.
This research summary is for educational purposes and should not replace professional medical advice. The TARGET-D trial shows that vitamin D supplementation did not significantly prevent major heart problems in heart attack survivors, but individual results may vary. If you have had a heart attack or have heart disease, consult with your cardiologist or primary care physician before starting any supplement regimen, including vitamin D. Do not stop taking prescribed heart medications or make changes to your treatment plan based on this information. This summary reflects the findings of one study; always discuss new research with your healthcare provider to determine how it applies to your specific situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.